• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌中的拟激酶作用。

The role of pseudokinases in cancer.

机构信息

Department of Cancer and Surgery, Imperial College, Hammersmith Hospital Campus, Du Cane Road, London, W12 ONN, UK.

出版信息

Cell Signal. 2012 Jun;24(6):1173-84. doi: 10.1016/j.cellsig.2012.01.017. Epub 2012 Feb 4.

DOI:10.1016/j.cellsig.2012.01.017
PMID:22330072
Abstract

Kinases play a critical role in regulating many cellular functions including development, differentiation and proliferation. To date, over 518 proteins with kinase activity, comprising ~2-3% of total cellular proteins, have been identified from within the human kinome. Interestingly, approximately 10% of kinases are categorised as pseudokinases since they lack one or more conserved catalytic residues within their kinase domain and were originally thought to have no enzymatic activity. Recently, there has been strong evidence to suggest that some pseudokinsases can not only function as scaffold proteins, but may also possess kinase activity leading to modulation of cell signalling pathways. Altered activity of these pseudokinases can result in impaired cellular function, particularly in malignancies. In this review we are discussing recent evidence that apart from a scaffolding role, pseudokinases also orchestrate cellular processes as active kinases per se in signalling pathways of malignant cells.

摘要

激酶在调节许多细胞功能中起着关键作用,包括发育、分化和增殖。迄今为止,已经从人类激酶组中鉴定出超过 518 种具有激酶活性的蛋白质,约占总细胞蛋白的 2-3%。有趣的是,大约 10%的激酶被归类为假激酶,因为它们在激酶结构域内缺乏一个或多个保守的催化残基,最初被认为没有酶活性。最近有强有力的证据表明,一些假激酶不仅可以作为支架蛋白发挥作用,而且还可能具有激酶活性,从而调节细胞信号通路。这些假激酶活性的改变会导致细胞功能受损,特别是在恶性肿瘤中。在这篇综述中,我们讨论了最近的证据,除了支架作用外,假激酶还作为活性激酶本身在恶性细胞的信号通路中协调细胞过程。

相似文献

1
The role of pseudokinases in cancer.癌中的拟激酶作用。
Cell Signal. 2012 Jun;24(6):1173-84. doi: 10.1016/j.cellsig.2012.01.017. Epub 2012 Feb 4.
2
The dual function of KSR1: a pseudokinase and beyond.KSR1 的双重功能:既是拟激酶又是超越拟激酶。
Biochem Soc Trans. 2013 Aug;41(4):1078-82. doi: 10.1042/BST20130042.
3
Metal coordination in kinases and pseudokinases.激酶和伪激酶中的金属配位
Biochem Soc Trans. 2017 Jun 15;45(3):653-663. doi: 10.1042/BST20160327.
4
A pickup in pseudokinase activity.蛋白激酶活性的回升。
Biochem Soc Trans. 2013 Aug;41(4):987-94. doi: 10.1042/BST20130110.
5
Pseudokinases-remnants of evolution or key allosteric regulators?假激酶——进化的残余还是关键的变构调节剂?
Curr Opin Struct Biol. 2010 Dec;20(6):772-81. doi: 10.1016/j.sbi.2010.10.001. Epub 2010 Nov 10.
6
Genome-wide and structural analyses of pseudokinases encoded in the genome of Arabidopsis thaliana provide functional insights.对拟激酶编码的基因组进行全基因组和结构分析,为其功能提供了新的见解。
Proteins. 2020 Dec;88(12):1620-1638. doi: 10.1002/prot.25981. Epub 2020 Aug 20.
7
The secret life of kinases: insights into non-catalytic signalling functions from pseudokinases.激酶的隐秘生活:来自假激酶的非催化信号功能洞察
Biochem Soc Trans. 2017 Jun 15;45(3):665-681. doi: 10.1042/BST20160331.
8
Prospects for pharmacological targeting of pseudokinases.针对假激酶的药理学靶向的前景。
Nat Rev Drug Discov. 2019 Jul;18(7):501-526. doi: 10.1038/s41573-019-0018-3.
9
Going for broke: targeting the human cancer pseudokinome.孤注一掷:靶向人类癌症假激酶组
Biochem J. 2015 Jan 15;465(2):195-211. doi: 10.1042/BJ20141060.
10
Kinases and pseudokinases: lessons from RAF.激酶和拟激酶:从 RAF 中得到的启示。
Mol Cell Biol. 2014 May;34(9):1538-46. doi: 10.1128/MCB.00057-14. Epub 2014 Feb 24.

引用本文的文献

1
The role of tribbles homolog 2 in cell proliferation.TRIB2在细胞增殖中的作用。
Cell Commun Signal. 2025 Jan 6;23(1):5. doi: 10.1186/s12964-024-01985-0.
2
Recent insights into the therapeutic strategies targeting the pseudokinase PTK7 in cancer.近期针对癌症中伪激酶 PTK7 的治疗策略的新见解。
Oncogene. 2024 Jun;43(26):1973-1984. doi: 10.1038/s41388-024-03060-x. Epub 2024 May 21.
3
Kinome-Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma.激酶组全合成致死筛选鉴定 PANK4 为胶质母细胞瘤替莫唑胺耐药的调节剂。
Adv Sci (Weinh). 2024 Apr;11(15):e2306027. doi: 10.1002/advs.202306027. Epub 2024 Feb 14.
4
Plasmodium pseudo-Tyrosine Kinase-like binds PP1 and SERA5 and is exported to host erythrocytes.疟原虫假酪氨酸激酶样蛋白与 PP1 和 SERA5 结合,并被输出到宿主红细胞中。
Sci Rep. 2019 May 31;9(1):8120. doi: 10.1038/s41598-019-44542-3.
5
Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.现代癌症治疗的突破与难以捉摸的心脏毒性:关键的研究与实践差距、挑战及见解
Med Res Rev. 2018 Jan;38(1):325-376. doi: 10.1002/med.21463. Epub 2017 Sep 1.
6
TRIB3 suppresses tumorigenesis by controlling mTORC2/AKT/FOXO signaling.TRIB3通过调控mTORC2/AKT/FOXO信号通路抑制肿瘤发生。
Mol Cell Oncol. 2015 Apr 18;2(3):e980134. doi: 10.4161/23723556.2014.980134. eCollection 2015 Jul-Sep.
7
MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.微小RNA-497通过靶向KSR1抑制肿瘤生长并增强对5-氟尿嘧啶治疗的化学敏感性。
Oncotarget. 2016 Jan 19;7(3):2660-71. doi: 10.18632/oncotarget.6545.
8
Nucleotide-binding mechanisms in pseudokinases.伪激酶中的核苷酸结合机制。
Biosci Rep. 2015 Nov 20;36(1):e00282. doi: 10.1042/BSR20150226.
9
The many-faced KSR1: a tumor suppressor in breast cancer.多面的KSR1:乳腺癌中的一种肿瘤抑制因子。
Oncoscience. 2015 Aug 25;2(8):669-70. doi: 10.18632/oncoscience.219. eCollection 2015.
10
Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer.小细胞肺癌中循环肿瘤细胞的受体酪氨酸激酶表达
Oncoscience. 2015 Jul 31;2(7):629-34. doi: 10.18632/oncoscience.179. eCollection 2015.